Summit Financial Wealth Advisors, LLC Viking Therapeutics, Inc. Transaction History
Summit Financial Wealth Advisors, LLC
- $440 Million
- Q2 2024
A detailed history of Summit Financial Wealth Advisors, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Summit Financial Wealth Advisors, LLC holds 4,095 shares of VKTX stock, worth $257,739. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,095
Previous 2,995
36.73%
Holding current value
$257,739
Previous $245,000
11.43%
% of portfolio
0.05%
Previous 0.06%
Shares
10 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$636 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$379 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$322 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$142 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$117 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.83B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...